title: Sclerosing bone dysplasias: neurologic assessment and management.
abstract: OBJECTIVE
  Sclerosing bone dysplasias are rare genetic disorders of bone remodeling in which excessive bone formation takes place, resulting in encroachment on neural structures. The infant usually appears normal at birth, and the first sign of a problem only comes when a neurologic deficit develops, usually in the form of an acute facial palsy. Although less than 300 cases have been published, these conditions should always be considered in the differential diagnosis of facial nerve palsy, especially in children.
  
  
  RESULTS
  This review highlights the neurologic presentation and assessment as well as the management of sclerosing bone dysplasias. An exciting development is the recent discovery of the sclerosteosis (SOST) gene, which is involved with excessive bone formation in sclerosteosis and Van Buchem disease. Researchers in bone metabolism and pharmaceutical companies are now utilizing this knowledge to develop a medicine for osteoporosis.
  
  
  CONCLUSIONS
  In children and young adults an acute facial palsy, especially if it is recurrent, as well as a conductive hearing loss may be the first sign of a sclerosing bone dysplasia.
authors.affiliation: 1 Military Hospital, Thaba Tshwane, Pretoria, South Africa. ahofmeyr71@hotmail.com
authors.forename: Louis M
authors.initials: LM
authors.lastname: Hofmeyr
authors.forename: Herman
authors.initials: H
authors.lastname: Hamersma
mesh_terms: D001707:Biopsy, Needle; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D006314:Hearing Loss, Conductive / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000628:therapy; D009460:Neurologic Examination; D010009:Osteochondrodysplasias / Q000175:diagnosis / Q000628:therapy; D010026:Osteosclerosis / Q000175:diagnosis* / Q000628:therapy*; D010036:Otolaryngology / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index
chemical_list: D019485:Bone Morphogenetic Proteins